1270EGP
- Active ingredient
- sofosbuvir+velpatasvir
- Strength
- 400/100 mg
- Form
- tablet
- Manufacturer
- marcyrl
- Route
- oral.solid
Uses
Used for treatment of chronic hepatitis C virus infection across multiple genotypes in appropriate patients.
Do not use if
Use is contraindicated with rifampin due to significant drug interaction.
Side effects
Common adverse effects include headache, fatigue, nausea, and diarrhea.
Warnings
Screen for current or prior hepatitis B infection before treatment because reactivation may occur.
How it works
A direct-acting antiviral combination that inhibits key viral proteins required for hepatitis C replication.
Storage
Store below 30°C in the original container.